AKTOCYTE 750MG

Product Description

. What is AKTOCYTE 750 MG?
AKTOCYTE 750 MG is a nutraceutical product developed for supportive care, particularly in patients receiving cancer radiotherapy. BARC/DAE describes AKTOCYTE as a regenerative nutraceutical and an adjuvant to cancer radiotherapy.

2. What is AKTOCYTE 750 MG used for?
It is used as supportive therapy for managing certain side effects associated with pelvic radiotherapy, particularly radiation-induced tissue injury.

3. Can AKTOCYTE 750 MG be used during cancer treatment?
It may be used as an adjunct/supportive product, but it should not replace the cancer treatment prescribed by the oncologist.

4. How should AKTOCYTE 750 MG be taken?
Take it exactly as directed by your doctor or healthcare professional. Some current product listings recommend taking the tablet orally with water, preferably before meals.

5. Can I take AKTOCYTE 750 MG without consulting a doctor?
For patients undergoing cancer treatment or radiotherapy, consultation with the treating doctor is recommended before starting it.

6. Does AKTOCYTE 750 MG cure cancer?
No. It should not be considered a cancer cure and should not replace chemotherapy, radiotherapy, surgery, immunotherapy, or other prescribed cancer treatment.

7. Are there any side effects?
Reported information suggests it is generally well tolerated, but individual reactions can occur. Contact your healthcare professional if you experience unusual or persistent symptoms.

8. Can pregnant or breastfeeding women take AKTOCYTE 750 MG?
Pregnant or breastfeeding women should consult their healthcare professional before using it.

9. Can AKTOCYTE 750 MG be taken with other medicines?
Tell your doctor about all prescription medicines, OTC medicines and supplements you are taking before starting AKTOCYTE.

10. How should AKTOCYTE 750 MG be stored?
Store it according to the instructions printed on the product packaging, away from excessive heat and moisture, and keep it out of reach of children.

11. Is AKTOCYTE 750 MG a chemotherapy medicine?
No. It is described as a supportive/regenerative nutraceutical, rather than a conventional chemotherapy drug.

12. Who should decide the dose?
The treating physician/healthcare professional should decide the appropriate dose and duration based on the patient's treatment and clinical condition.